T-CELL FUNCTION IN-VITRO IS AN INDEPENDENT PROGRESSION MARKER FOR AIDS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED ASYMPTOMATIC SUBJECTS

被引:74
作者
ROOS, MTL
MIEDEMA, F
KOOT, M
TERSMETTE, M
SCHAASBERG, WP
COUTINHO, RA
SCHELLEKENS, PTA
机构
[1] NETHERLANDS RED CROSS, BLOOD TRANSFUS SERV, CENT LAB, DEPT CLIN VIROIMMUNOL, 1066 CX AMSTERDAM, NETHERLANDS
[2] UNIV AMSTERDAM, EXPTL & CLIN IMMUNOL LAB, AMSTERDAM, NETHERLANDS
[3] ACAD MED CTR, DEPT INTERNAL MED, CLIN IMMUNOL UNIT, AMSTERDAM, NETHERLANDS
[4] ACAD MED CTR, MUNICIPAL HLTH SERV, AMSTERDAM, NETHERLANDS
关键词
D O I
10.1093/infdis/171.3.531
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The predictive value of low T cell reactivity to CD3 monoclonal antibodies for development of AIDS was evaluated and compared with low CD4(+) cell numbers and the presence of syncytium-inducing human immunodeficiency virus (HIV) variants in 122 seropositive asymptomatic homosexual men for 4.5 years. Low T cell reactivity was a strong predictor for progression to AIDS in a multivariate proportional hazards analysis using these markers as covariates at entry and as time-dependent covariates. The combination of the three markers was associated with development of AIDS in 6 of 7 men within 15 months. In contrast, the group that lacked any of these markers had a very low risk (11%) for developing AIDS. In groups with one or two of these three markers, progression rates were 33% and 66%, respectively. These data demonstrate that measurement of T cell function in vitro is of value for staging of HIV infection and may be useful for monitoring therapy.
引用
收藏
页码:531 / 536
页数:6
相关论文
共 24 条
[1]   ACQUIRED IMMUNE DYSFUNCTION IN HOMOSEXUAL MEN - IMMUNOLOGICAL PROFILES [J].
AMMANN, AJ ;
ABRAMS, D ;
CONANT, M ;
CHUDWIN, D ;
COWAN, M ;
VOLBERDING, P ;
LEWIS, B ;
CASAVANT, C .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1983, 27 (03) :315-325
[2]   DELAYED-TYPE HYPERSENSITIVITY SKIN TESTING PREDICTS PROGRESSION TO AIDS IN HIV-INFECTED PATIENTS [J].
BLATT, SP ;
HENDRIX, CW ;
BUTZIN, CA ;
FREEMAN, TM ;
WARD, WW ;
HENSLEY, RE ;
MELCHER, GP ;
DONOVAN, DJ ;
BOSWELL, RN .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (03) :177-184
[3]   PHARMACODYNAMIC MODELING OF LYMPHOCYTOPENIA AND WHOLE-BLOOD LYMPHOCYTE-CULTURES IN PREDNISOLONE-TREATED INDIVIDUALS [J].
BLOEMENA, E ;
KOOPMANS, RP ;
WEINREICH, S ;
VANBOXTEL, CJ ;
SCHELLEKENS, PTA .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1990, 57 (03) :374-386
[4]   WHOLE-BLOOD LYMPHOCYTE-CULTURES [J].
BLOEMENA, E ;
ROOS, MTL ;
VANHEIJST, JLAM ;
VOSSEN, JMJJ ;
SCHELLEKENS, PTA .
JOURNAL OF IMMUNOLOGICAL METHODS, 1989, 122 (02) :161-167
[5]   HIV-1 BIOLOGICAL PHENOTYPE AND THE DEVELOPMENT OF ZIDOVUDINE RESISTANCE IN RELATION TO DISEASE PROGRESSION IN ASYMPTOMATIC INDIVIDUALS DURING TREATMENT [J].
BOUCHER, CAB ;
LANGE, JMA ;
MIEDEMA, FF ;
WEVERLING, GJ ;
KOOT, M ;
MULDER, JW ;
GOUDSMIT, J ;
KELLAM, P ;
LARDER, BA ;
TERSMETTE, M .
AIDS, 1992, 6 (11) :1259-1264
[6]   CD4+ LYMPHOCYTES ARE AN INCOMPLETE SURROGATE MARKER FOR CLINICAL PROGRESSION IN PERSONS WITH ASYMPTOMATIC HIV-INFECTION TAKING ZIDOVUDINE [J].
CHOI, SS ;
LAGAKOS, SW ;
SCHOOLEY, RT ;
VOLBERDING, PA .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (09) :674-680
[7]   ZIDOVUDINE IN PERSONS WITH ASYMPTOMATIC HIV-INFECTION AND CD4+ CELL COUNTS GREATER-THAN 400 PER CUBIC MILLIMETER [J].
COOPER, DA ;
GATELL, JM ;
KROON, S ;
CLUMECK, N ;
MILLARD, J ;
GOEBEL, FD ;
BRUUN, JN ;
STINGL, G ;
MELVILLE, RL ;
GONZALEZLAHOZ, J ;
STEVENS, JW ;
FIDDIAN, AP .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (05) :297-303
[8]  
CROWE SM, 1991, J ACQ IMMUN DEF SYND, V4, P770
[9]  
DEWOLF F, 1988, J INFECT DIS, V158, P615, DOI 10.1093/infdis/158.3.615
[10]   DIFFERENCES IN CLINICAL COURSE IN ZIDOVUDINE-TREATED ASYMPTOMATIC HIV-INFECTED MEN ASSOCIATED WITH T-CELL FUNCTION AT INTAKE [J].
GRUTERS, RA ;
TERPSTRA, FG ;
LANGE, JMA ;
ROOS, MT ;
HARKEMA, T ;
MULDER, JW ;
DEWOLF, F ;
SCHELLEKENS, PTA ;
MIEDEMA, F .
AIDS, 1991, 5 (01) :43-47